Article Details
Retrieved on: 2021-08-09 12:56:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Pfizer has developed a respiratory syncytial virus (RSV) vaccine that was 100% effective against disease in a small human challenge trial. The result ...
Article found on: www.freethink.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here